Stifel reiterates Philip Morris stock Buy rating on smoke-free growth

Stifel has reaffirmed its Buy rating and $205 price target on Philip Morris International Inc. (PM), citing the company's growth potential in smoke-free products. The stock is trading at $190.48, which is around an 8% upside from the analyst's target price. With a market capitalization of $296.9 billion and a PEG ratio of 0.86, PM is offering an appealing valuation considering its near-term earnings growth.

The firm has also provided a primer book detailing the company's overview, management questions, models, assumptions, and a detailed valuation analysis, incorporating industry data and in-depth reviews of its divisions and major markets. Stifel's analysis specifically highlights the growth prospects of smoke-free products like IQOS and ZYN, which are expected to bolster the company's expansion opportunities and enhance margin expansion.

The company currently boasts substantial gross profit margins of 67.48%. In addition to maintaining its bullish stance on PM, Stifel has offered an extra 10 exclusive tips for the stock and provides comprehensive Pro Research Reports for over 1,400+ US stocks. The firm's positive outlook has been reinforced by recent developments, such as Philip Morris International's strong second-quarter earnings, surpassing expectations with earnings per share of $2.20.

The company has also been granted authorization by the U.S. Food and Drug Administration to market 11 ZYN Ultra nicotine pouch products, including various nicotine strengths. Moreover, Philip Morris plans to invest an additional $1.2 billion in a Colorado manufacturing facility for ZYN nicotine pouches by 2028, amid growing competition in the nicotine market.